-
Kenya's economy faces climate change risks: World Bank
-
From rations to G20's doorstep: Poland savours economic 'miracle'
-
Rural India powers global AI models
-
Equities, metals, oil rebound after Asia-wide rout
-
Italy's spread-out Olympics face transport challenge
-
Paying for a selfie: Rome starts charging for Trevi Fountain
-
Musk merges xAI into SpaceX in bid to build space data centers
-
New York records 13 cold-related deaths since late January
-
In post-Maduro Venezuela, pro- and anti-government workers march for better pay
-
Late-January US snowstorm wasn't historically exceptional: NOAA
-
Punctuality at Germany's crisis-hit railway slumps
-
Europe observatory hails plan to abandon light-polluting Chile project
-
Oil slides, gold loses lustre as Iran threat recedes
-
Russian captain found guilty in fatal North Sea crash
-
Disney earnings boosted by theme parks, as CEO handover nears
-
France demands 1.7 bn euros in payroll taxes from Uber: media report
-
Latest Epstein file dump rocks UK royals, politics
-
More baby milk recalls in France after new toxin rules
-
Germany hit by nationwide public transport strike
-
WHO chief says turmoil creates chance for reset
-
European stocks rise as gold, oil prices tumble
-
Trump says US talking deal with 'highest people' in Cuba
-
Olympic Games in northern Italy have German twist
-
At Grammys, 'ICE out' message loud and clear
-
Steven Spielberg earns coveted EGOT status with Grammy win
-
Kendrick Lamar, Bad Bunny, Lady Gaga triumph at Grammys
-
Japan says rare earth found in sediment retrieved on deep-sea mission
-
Oil tumbles on Iran hopes, precious metals hit by stronger dollar
-
Kendrick Lamar, Bad Bunny, Lady Gaga win early at Grammys
-
Surging euro presents new headache for ECB
-
US talking deal with 'highest people' in Cuba: Trump
-
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades
-
Hans Vestberg, Former Verizon Chairman and CEO, Joins Digipower X As Senior Advisor
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
French IT giant Capgemini to sell US subsidiary after row over ICE links
-
New Epstein accuser claims sexual encounter with ex-prince Andrew: report
-
Snowstorm disrupts travel in southern US as blast of icy weather widens
-
Afghan returnees in Bamiyan struggle despite new homes
-
Mired in economic trouble, Bangladesh pins hopes on election boost
-
Chinese cash in jewellery at automated gold recyclers as prices soar
-
Nvidia boss insists 'huge' investment in OpenAI on track
-
Snowstorm barrels into southern US as blast of icy weather widens
-
Ex-prince Andrew again caught up in Epstein scandal
-
How Lego got swept up in US-Mexico trade frictions
-
Snow storm barrels into southern US as blast of icy weather widens
-
Ex-prince Andrew dogged again by Epstein scandal
-
'Malfunction' cuts power in Ukraine. Here's what we know
-
Women in ties return as feminism faces pushback
-
Ship ahoy! Prague's homeless find safe haven on river boat
Philips chops back US tariff bill
Dutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially estimated, sending its share price surging.
The company had originally estimated in April that US tariffs could cost it 250 to 300 million euros this year after President Donald Trump unveiled a 20 percent tariff rate for goods from the European Union.
Brussels and Washington reached a deal over the weekend that will see goods from the EU face a baseline 15 percent levy when imported into the United States.
It said Tuesday it now expects between 150 and 200 million euros impact from US tariffs this year.
Chief executive Roy Jakobs said Philips updated "the guidance because we have certainty now around what is happening between the EU and the US."
Shares in Philips jumped more than 10 percent during morning trading, while the Amsterdam market rose around 0.4 percent overall.
The trade deal has come under widespread criticism in Europe as having been lopsided, saddling its manufacturers with a costly 15 percent rate with little in return from the US as certainty is a relative concept given Trump's propensity to change positions.
Jakobs said that certainty "is what we value in" in the deal, while acknowledging "it's a painful additional cost we have to carry".
The company still targets a one to three percent increase in annual sales.
Second quarter net profit fell by 47 percent to 240 million euros, but last year's performance was boosted by exceptional income from insurance payouts linked to long-running issues with its sleep apnoea machines.
Sales slid by 2.8 percent to 4.3 billion euros, although they edged higher on a comparable basis that excludes currency changes. The company also noted orders rose by six percent on a comparable basis.
The appreciation of the euro relative to the dollar and other currencies has been crimping the results of European companies as their revenues abroad result in fewer euros on the balance sheet.
Long known for its light bulbs and television sets, the Dutch company has refocused its business towards medical equipment.
Y.Jeong--CPN